Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Histone deacetylases positively regulate transcription through the elongation machinery

ABSTRACT: Chromatin immunoprecipitation sequencing (ChIP-seq) analysis of elongation factors in breast cancer cells upon HDAC inhibition.

INSTRUMENT(S): Illumina HiSeq 2000

ORGANISM(S): Homo sapiens

SUBMITTER: Tae Hoon Kim

PROVIDER: E-MTAB-3631 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Similar Datasets

Time course ChIP-seq analysis of the human GM12878 lymphoblasts upon Sendai Virus infection

Project description:Time course ChIP-seqwas performed to determine global changes in histone H3 lysine 27 acetylation (H3K27Ac) at enhancers upon Sendai Virus infection.

2018-10-07 | E-MTAB-6050 | biostudies-arrayexpress

Histone deacetylases positively regulate transcription through the elongation machinery

Project description:Global run-on sequencing (GRO-seq) analysis of breast cancer cells upon perturbations of transcription elongation regulators.

2015-10-20 | E-MTAB-3626 | biostudies-arrayexpress

Primary monocyte to macrophage differentiation involves significant changes in chromosome conformation different from cultured THP-1 cells

Project description:Use human native monocyte and induce to macrophae by GM-CSF, reserach the chromatin conformation of these two cell types.

2021-02-23 | E-MTAB-8262 | biostudies-arrayexpress

MBD2 modulates heterochromatin architecture and composition

Project description:Heterochromatin (HC) is essential for nuclear integrity, genome stability, and gene regulation with pericentric heterochromatin (PCH) playing a key role. However, the mechanisms governing PCH compartmentalization remain poorly understood. Recent studies suggest that phase separation (PS) underlies the organization of various subnuclear compartments, including PCH. In this study, we integrated spatial proteomics, in vitro phase separation assays, and advanced PS prediction tools to identify and characterize candidate PS scaffold proteins involved in HC compartmentalization, particularly in PCH. We found that HC forms dynamic, phase-separated condensates that selectively enrich specific proteins. Approximately 1,000 HC PS-associated proteins were predicted, with around 250 predicted to possess scaffold PS properties. Further subcellular analysis identified 20 potential PS scaffold proteins in PCH, including Methyl-CpG binding domain protein 2 (MBD2). MBD2, a member of the NuRD complex, was shown to undergo LLPS via coiled-coil-mediated homooligomerization, forming liquid-like condensates that likely regulate PCH organization, as well as MBD-mC-mediated PPPS. This study advances our understanding of PCH compartmentalization by highlighting the role of MBD2 in PCH dynamics and provides new insights into the molecular mechanisms underlying nuclear architecture and opens avenues for future research into genome regulation and stability.

2025-12-29 | PXD055626 | Pride

Dissection of acetylomic profiles in T cell lymphoma following histone deacetylases inhibition

Project description:The aim was to dissect molecular changes in histone and non-histone protein acetylation dynamics following the genetic or pharmacological inhibition of HDAC activity in a model of Anaplastic Large Cell Lymphoma (ALCL), a T cell non-Hodgkin lymphoma, predominantly found in children and adolescents.

2022-10-14 | PXD030503 | Pride

Arg-C Ultra simplifies histone preparation for LC-MS/MS

Project description:Using mammalian histone extract, we demonstrate that Arg-C Ultra facilitates histone preparation for LC-MS/MS. We show the performance of Arg-C Ultra in terms of digestion specificity, number of modified forms identified, and yield of quantitative information compared with standard Arg-C and trypsin digestion combined with chemical derivatization with trimethylacetic anhydride. We show that chemical derivatization at the peptide level, i.e., after Arg-C Ultra digestion, is still necessary to improve the quantification of short histone peptidoforms as well as positional isomers.

2025-06-30 | PXD059514 | Pride

p53-mediated DNA looping at CRMP4 promoter in colorectal cancer

Project description:An MNase-based proximity ligation assay analogous to a targeted Micro-4C approach was performed to study the DNA looping at CRMP4 promoter in colorectal cancer. Total four p53 binding sites (PBR1, PBR2, PBR3, PBR4) at CRMP4 promoter were investigated in each group. Total eleven groups (NC, PBR1 deletion by CRISPR-Cas9, PBR2 deletion, PBR3 deletion, PBR4 deletion, p53 knockdown, HIF1a knockdown, p53 TET domain deletion, p53 TET domain deletion plus wild type p53 overexpression in HCT116 cells in default, p53 knockdown in RKO cells, p53 knockdown in HCT8 cells) were enrolled in this study.

2026-02-19 | E-MTAB-16604 | biostudies-arrayexpress

Gene expression profiling of drug-tolerant persister BT474 breast cancer cells derived from lapatinib treatment

Project description:Acquired drug resistance prevents targeted cancer therapy from achieving stable and complete responses. Emerging evidence implicates a key role for nonmutational mechanisms including changes in cell state during early stages of acquired drug resistance. Targeting nonmutational resistance may therefore present a therapeutic opportunity to eliminate residual surviving tumor cells and impede relapse. A variety of cancer cell lines harbor quiescent, reversibly drug-tolerant âpersisterâ cells which survive cytotoxic drugs including targeted therapies and chemotherapies. These persister cells survive drug through nonmutational mechanisms which are poorly understood. Specifically targeting persister cells is a promising strategy to prevent tumor relapse. We sought to identify therapeutically exploitable vulnerabilities in persister cells using the HER2-amplified breast cancer line BT474 as an experimental model. Similar to other persister cell models, upon treatment with the HER2 inhibitor lapatinib (2uM concentration) for nine or more days, the majority of BT474 cells die, revealing a small population of quiescent surviving persister cells. Removal of lapatinib allows the persister cells to regrow and to re-acquire sensitivity to lapatinib. Subsequent lapatinib treatment re-derives persister cells. The reversibility of persister cell drug resistance indicates a nonmutational resistance mechanism. Here we provide RNAseq gene expression profiling data generated from parental BT474 cells compared to BT474 persister cells generated from nine days of treatment with 2 uM lapatinib. These data can be used to identify genes and pathways which are upregulated in persister cells, revealing potential therapeutic targets. 3 biological replicates of BT474 persister cells, two biological replicates of BT474 parental cells

2016-07-28 | E-GEOD-84896 | biostudies-arrayexpress

Site-specific glycan analysis of ErbB2 in breast cancer cell BT474

Project description:This study provides site-specific profiles of asparagine-linked and serine/threonine-linked glycosylations on ErbB2, a therapeutic target RTK for ErbB2-positive cancer, through structural analysis of recombinant ErbB2 extracellular region and endogenous ErbB2 from ErbB2-positive breast cancer cells. Furthermore, comparison of the N-glycosylated structures of the extracellular regions of ErbB2 and its homologue, the epidermal growth factor receptor (EGFR), showed differences in the distribution and density of N-glycans on both molecules, providing new insights into the different activation mechanisms of ErbB2 and EGFR from a glycan perspective.

2024-05-24 | PXD039838 | Pride

Dynamics of replication-independent histone turnover in budding yeast

Project description:This SuperSeries is composed of the following subset Series: GSE6664: Ratios for unsync cells GSE6665: Ratios for G1 arrested cells (Printed array) GSE6666: Ratios for G1 arrested cells (Agilent array) GSE6667: PolII occupancy GSE6668: Nucleosome occupancy GSE6669: H3 occupancy GSE6670: Ratios for Htz1D cells (Agilent array) Keywords: SuperSeries Refer to individual Series

2010-06-11 | E-GEOD-6680 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data